dapsone and amg531

dapsone has been researched along with amg531 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diez-Ewald, M; Vizcaíno, G; Vizcaíno-Carruyo, J1
Audia, S; Bonnotte, B; Godeau, B1
Aboud, N; Depré, F; Mayer, B; Salama, A1

Reviews

1 review(s) available for dapsone and amg531

ArticleYear
[Treatment of chronic immune thrombocytopenic purpura. Looking for something better. Review].
    Investigacion clinica, 2009, Volume: 50, Issue:1

    Topics: Adrenal Cortex Hormones; Antigens, Human Platelet; Autoantibodies; Benzoates; Blood Platelets; Clinical Trials as Topic; Combined Modality Therapy; Cost-Benefit Analysis; Dapsone; Helicobacter Infections; Helicobacter pylori; Humans; Hydrazines; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Models, Immunological; Molecular Mimicry; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Splenectomy; Thrombopoiesis

2009

Other Studies

2 other study(ies) available for dapsone and amg531

ArticleYear
Is there still a place for "old therapies" in the management of immune thrombocytopenia?
    La Revue de medecine interne, 2016, Volume: 37, Issue:1

    Topics: Benzoates; Danazol; Dapsone; Humans; Hydrazines; Hydroxychloroquine; Immunoglobulins, Intravenous; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Thrombopoietin; Vinca Alkaloids

2016
Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Benzoates; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Dapsone; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Remission Induction; Retrospective Studies; Rho(D) Immune Globulin; Rituximab; Splenectomy; Thrombopoietin; Treatment Outcome; Young Adult

2018